Vestal-Point-Capital-Lp

AI_NATIVE detailed information: This accession holds the following tickers:[
  null,
  "KNSA",
  "NUVL",
  "ASND",
  "CNTA",
  "INSM",
  "FOLD",
  "ARCT",
  "GLPG",
  "BCAX",
  "ATXS",
  "GPCR",
  "IMTX",
  "SVRA",
  "TYRA",
  "LQDA",
  "NRIX",
  "ANRO",
  "ALEC",
  "APLT",
  "ATRA",
  "ESTA",
  "GERN",
  "SRRK",
  "FATE",
  "KALV",
  "MGNX",
  "LXEO",
  "OKUR",
  "STRO",
  "ZYME",
  "GEHC",
  "TRAW",
  "SLDB",
  "TENX",
  "MLTX",
  "ACLX",
  "QURE",
  "COGT",
  "DYN",
  "PASG",
  "GMED",
  "SRPT",
  "PRGO",
  null,
  "CDTX",
  "ITOS",
  "URGN",
  "VRNA",
  "VTYX",
  "VYGR",
  "XENE",
  "VERA",
  "RARE",
  "IMVT",
  "BDTX",
  "BRKR",
  "CLDX",
  "CRNX",
  "DHR",
  "DAWN",
  "CYTK",
  "DNTH"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 63
Total Value: 1400316542
Accession Number: 0001974915-25-000005
Form Type: 13F-HR
CIK: vestal-point-capital-lp
Manager Name: Vestal-Point-Capital-Lp

Data Enrichment

97% identified

61 identified2 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

63 positions • $1.4B total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 3 of 4

Sort by:

Immunovant, Inc.

IMVT|45258J102

Shares:350.0K

Value:$6.0M

% of Portfolio:0.4% ($6.0M/$1.4B)

Zymeworks Inc.

ZYME|98985Y108

Shares:500.0K

Value:$6.0M

% of Portfolio:0.4% ($6.0M/$1.4B)

Applied Therapeutics, Inc.

APLT|03828A101

Shares:11.5M

Value:$5.6M

% of Portfolio:0.4% ($5.6M/$1.4B)

iTeos Therapeutics, Inc.

ITOS|46565G104

Shares:900.0K

Value:$5.4M

% of Portfolio:0.4% ($5.4M/$1.4B)

GALAPAGOS NV

GLPG|36315X101

Shares:200.0K

Value:$5.0M

% of Portfolio:0.4% ($5.0M/$1.4B)

Voyager Therapeutics, Inc.

VYGR|92915B106

Shares:1.2M

Value:$4.2M

% of Portfolio:0.3% ($4.2M/$1.4B)

Lexeo Therapeutics, Inc.

LXEO|52886X107

Shares:1.1M

Value:$3.9M

% of Portfolio:0.3% ($3.9M/$1.4B)

Kiniksa Pharmaceuticals International, plc

KNSA|G52694109

Shares:169.9K

Value:$3.8M

% of Portfolio:0.3% ($3.8M/$1.4B)

Celldex Therapeutics, Inc.

CLDX|15117B202

Shares:198.6K

Value:$3.6M

% of Portfolio:0.3% ($3.6M/$1.4B)

OnKure Therapeutics, Inc.

OKUR|68277Q105

Shares:635.0K

Value:$2.7M

% of Portfolio:0.2% ($2.7M/$1.4B)

Ventyx Biosciences, Inc.

VTYX|92332V107

Shares:2.0M

Value:$2.3M

% of Portfolio:0.2% ($2.3M/$1.4B)

Arcturus Therapeutics Holdings Inc.

ARCT|03969T109

Shares:211.8K

Value:$2.2M

% of Portfolio:0.2% ($2.2M/$1.4B)

Passage BIO, Inc.

PASG|702712100

Shares:6.1M

Value:$2.2M

% of Portfolio:0.2% ($2.2M/$1.4B)

FATE THERAPEUTICS INC

FATE|31189P102

Shares:2.5M

Value:$2.0M

% of Portfolio:0.1% ($2.0M/$1.4B)

Alto Neuroscience, Inc.

ANRO|02157Q109

Shares:915.0K

Value:$2.0M

% of Portfolio:0.1% ($2.0M/$1.4B)

SUTRO BIOPHARMA, INC.

STRO|869367102

Shares:2.6M

Value:$1.7M

% of Portfolio:0.1% ($1.7M/$1.4B)

29286M105

Shares:370.0K

Value:$1.7M

% of Portfolio:0.1% ($1.7M/$1.4B)

Alector, Inc.

ALEC|014442107

Shares:504.5K

Value:$620.6K

% of Portfolio:0.0% ($620.6K/$1.4B)

Atara Biotherapeutics, Inc.

ATRA|046513206

Shares:94.1K

Value:$558.9K

% of Portfolio:0.0% ($558.9K/$1.4B)

Traws Pharma, Inc.

TRAW|68232V884

Shares:175.0K

Value:$402.5K

% of Portfolio:0.0% ($402.5K/$1.4B)

Instrument	Shares		Other Manager	Value	% of Portfolio
Immunovant, Inc.(IMVTcusip45258J102)	350.0K	QoQ +677.77% (+305.0K) YoY NEW(+350.0K)	All Managers (Combined)	$6.0M	0.4% ($6.0M/$1.4B)	QoQ +436.62% (+$4.9M) YoY NEW(+$6.0M)
Zymeworks Inc.(ZYMEcusip98985Y108)	500.0K	QoQ +170.27% (+315.0K) YoY NEW(+500.0K)	All Managers (Combined)	$6.0M	0.4% ($6.0M/$1.4B)	QoQ +119.87% (+$3.2M) YoY NEW(+$6.0M)
Applied Therapeutics, Inc.(APLTcusip03828A101)	11.5M	QoQ 0.00% (-0) YoY +125.04% (-6.4M)	All Managers (Combined)	$5.6M	0.4% ($5.6M/$1.4B)	QoQ -42.89% (-$4.2M) YoY -83.81% (-$29.1M)
iTeos Therapeutics, Inc.(ITOScusip46565G104)	900.0K	QoQ 0.00% (-0) YoY NEW(+900.0K)	All Managers (Combined)	$5.4M	0.4% ($5.4M/$1.4B)	QoQ -22.26% (-$1.5M) YoY NEW(+$5.4M)
GALAPAGOS NV(GLPGcusip36315X101)	200.0K	QoQ +11.11% (+20.0K) YoY +53.84% (+70.0K)	All Managers (Combined)	$5.0M	0.4% ($5.0M/$1.4B)	QoQ +1.49% (+$74.0K) YoY +20.01% (+$838.0K)
Voyager Therapeutics, Inc.(VYGRcusip92915B106)	1.2M	QoQ +1.57% (-19.4K) YoY +108.23% (-649.4K)	All Managers (Combined)	$4.2M	0.3% ($4.2M/$1.4B)	QoQ -39.44% (-$2.8M) YoY -24.39% (-$1.4M)
Lexeo Therapeutics, Inc.(LXEOcusip52886X107)	1.1M	QoQ -5.31% (-63.8K) YoY +549.28% (+961.2K)	All Managers (Combined)	$3.9M	0.3% ($3.9M/$1.4B)	QoQ -50.06% (-$4.0M) YoY +43.68% (+$1.2M)
Kiniksa Pharmaceuticals International, plc(KNSAcusipG52694109)	169.9K	QoQ NEW(+169.9K) YoY NEW(+169.9K)	All Managers (Combined)	$3.8M	0.3% ($3.8M/$1.4B)	QoQ NEW(+$3.8M) YoY NEW(+$3.8M)
Celldex Therapeutics, Inc.(CLDXcusip15117B202)	198.6K	QoQ -34.87% (-106.4K) YoY NEW(+198.6K)	All Managers (Combined)	$3.6M	0.3% ($3.6M/$1.4B)	QoQ -53.22% (-$4.1M) YoY NEW(+$3.6M)
OnKure Therapeutics, Inc.(OKURcusip68277Q105)	635.0K	QoQ 0.00% (-0) YoY NEW(+635.0K)	All Managers (Combined)	$2.7M	0.2% ($2.7M/$1.4B)	QoQ -50.00% (-$2.7M) YoY NEW(+$2.7M)
Ventyx Biosciences, Inc.(VTYXcusip92332V107)	2.0M	QoQ 0.00% (-0) YoY NEW(+2.0M)	All Managers (Combined)	$2.3M	0.2% ($2.3M/$1.4B)	QoQ -47.48% (-$2.1M) YoY NEW(+$2.3M)
Arcturus Therapeutics Holdings Inc.(ARCTcusip03969T109)	211.8K	QoQ NEW(+211.8K) YoY NEW(+211.8K)	All Managers (Combined)	$2.2M	0.2% ($2.2M/$1.4B)	QoQ NEW(+$2.2M) YoY NEW(+$2.2M)
Passage BIO, Inc.(PASGcusip702712100)	6.1M	QoQ 0.00% (-0) YoY +35.55% (-1.6M)	All Managers (Combined)	$2.2M	0.2% ($2.2M/$1.4B)	QoQ -37.73% (-$1.3M) YoY -64.54% (-$3.9M)
FATE THERAPEUTICS INC(FATEcusip31189P102)	2.5M	QoQ +2.06% (-50.9K) YoY +214.48% (-1.7M)	All Managers (Combined)	$2.0M	0.1% ($2.0M/$1.4B)	QoQ -51.12% (-$2.1M) YoY -66.14% (-$3.9M)
Alto Neuroscience, Inc.(ANROcusip02157Q109)	915.0K	QoQ 0.00% (-0) YoY +266.00% (-665.0K)	All Managers (Combined)	$2.0M	0.1% ($2.0M/$1.4B)	QoQ -48.93% (-$1.9M) YoY -48.49% (-$1.9M)
SUTRO BIOPHARMA, INC.(STROcusip869367102)	2.6M	QoQ +1.16% (-30.0K) YoY NEW(+2.6M)	All Managers (Combined)	$1.7M	0.1% ($1.7M/$1.4B)	QoQ -64.22% (-$3.0M) YoY NEW(+$1.7M)
(cusip29286M105)✕	370.0K	QoQ 0.00% (-0) YoY NEW(+370.0K)	All Managers (Combined)	$1.7M	0.1% ($1.7M/$1.4B)	QoQ -32.63% (-$802.9K) YoY NEW(+$1.7M)
Alector, Inc.(ALECcusip014442107)	504.5K	QoQ NEW(+504.5K) YoY NEW(+504.5K)	All Managers (Combined)	$620.6K	0.0% ($620.6K/$1.4B)	QoQ NEW(+$620.6K) YoY NEW(+$620.6K)
Atara Biotherapeutics, Inc.(ATRAcusip046513206)	94.1K	QoQ -24.73% (-30.9K) YoY NEW(+94.1K)	All Managers (Combined)	$558.9K	0.0% ($558.9K/$1.4B)	QoQ -66.40% (-$1.1M) YoY NEW(+$558.9K)
Traws Pharma, Inc.(TRAWcusip68232V884)	175.0K	QoQ +133.33% (-100.0K) YoY NEW(+175.0K)	All Managers (Combined)	$402.5K	0.0% ($402.5K/$1.4B)	QoQ -39.56% (-$263.5K) YoY NEW(+$402.5K)